Related content

Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers

By Krupka Emmanuel   Venisse Nicolas   Lafay Claire   Gendre David   Diquet Bertrand   Bouquet Serge   Perault Marie-Christine  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 8, 2006-08 ,pp. : 653-659

Springer Publishing Company

Access to resources Recommend Favorite

Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 151-157

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of tofisopam on the single-oral-dose pharmacokinetics and pharmacodynamics of the cyp3a4 probe drug alprazolam

By Drabant Sándor   Tóth Mária   Bereczki Andrea   Bajnógel Judit   Tömlö Judit   Klebovich Imre  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 7, 2006-07 ,pp. : 587-588

Springer Publishing Company

Access to resources Recommend Favorite

CYP3A4 intron 6 C>T SNP (CYP3A4*22) encodes lower CYP3A4 activity in cancer patients, as measured with probes midazolam and erythromycin

By Elens Laure   Nieuweboer Annemieke   Clarke Stephen J   Charles Kellie A   de Graan Anne-Joy   Haufroid Vincent   Mathijssen Ron HJ   van Schaik Ron HN  

Pharmacogenomics, Vol. 14, Iss. 2, 2013-01 ,pp. : 137-149

Future Medicine

Access to resources Recommend Favorite

Pharmacokinetics of midazolam in CYP3A4- and CYP3A5-genotyped subjects

By Eap Chin   Buclin Thierry   Hustert Elisabeth   Bleiber Gabriela   Golay Kerry   Aubert Anne-Catherine   Baumann Pierre   Telenti Amalio   Kerb Reinhold  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 4, 2004-06 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite